Japanese Pharmaceuticals & Biotech Most Popular Stocks

Chugai Pharmaceutical

Market Cap: JP¥13.6t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

Takeda Pharmaceutical

Market Cap: JP¥7.6t

Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally.

Daiichi Sankyo Company

Market Cap: JP¥6.2t

Manufactures and sells pharmaceutical products in Japan, the United States, Europe, and internationally.

Otsuka Holdings

Market Cap: JP¥4.7t

Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.

Astellas Pharma

Market Cap: JP¥3.7t

Manufactures, markets, imports, and exports pharmaceuticals in Japan and internationally.

Shionogi

Market Cap: JP¥2.4t

Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.

Kyowa Kirin

Market Cap: JP¥1.3t

Engages in the research, development, manufacture, import/export, and market of pharmaceuticals products worldwide.

Eisai

Market Cap: JP¥1.3t

Engages in the research and development, manufacture, sale, and import and export of pharmaceuticals.

Ono Pharmaceutical

Market Cap: JP¥1.0t

Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.

Sumitomo Pharma

Market Cap: JP¥920.9b

Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia.

Santen Pharmaceutical

Market Cap: JP¥522.9b

Engages in the research and development, manufacturing, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally.

Nippon Shinyaku

Market Cap: JP¥380.8b

Manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally.

Hisamitsu Pharmaceutical

Market Cap: JP¥307.6b

Manufactures and sells pharmaceuticals in Japan.

Tsumura

Market Cap: JP¥303.1b

Engages in the production and sale of Kampo extract intermediates and granular Kampo formulations in Japan and internationally.

Sawai Group Holdings

Market Cap: JP¥272.4b

Together with subsidiaries, engages in the research and development, manufacture, and marketing of generic pharmaceuticals.

PeptiDream

Market Cap: JP¥214.0b

A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.

Kissei Pharmaceutical

Market Cap: JP¥192.8b

Researches, develops, manufactures, and sells pharmaceutical products primarily in Japan.

Towa Pharmaceutical

Market Cap: JP¥179.2b

Manufactures and sale ethical drugs in Japan.

Kaken Pharmaceutical

Market Cap: JP¥152.0b

Produces, markets, and sells medical products, medical devices, and agrochemicals in Japan and internationally.

GNI Group

Market Cap: JP¥134.2b

Engages in the research, development, manufacture, and sale of pharmaceutical drugs in Japan and internationally.

Mochida Pharmaceutical

Market Cap: JP¥125.3b

Manufactures and sells pharmaceuticals and healthcare products in Japan.

SanBio

Market Cap: JP¥121.7b

Develops, produces, and sells regenerative cell medicines for the central nervous system.

Takara Bio

Market Cap: JP¥95.7b

Engages in the businesses of reagents, equipment, contract services, and genetic medicine in Japan, China, the rest of Asia, the United States, Europe, and internationally.

Zeria Pharmaceutical

Market Cap: JP¥92.5b

Manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural and industrial chemicals, and reagents in Japan and internationally.

KYORIN Pharmaceutical

Market Cap: JP¥88.3b

Through its subsidiaries, researches and develops, manufactures, and sells ethical and generic drugs in Japan and internationally.

JCR Pharmaceuticals

Market Cap: JP¥86.9b

Engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan.

Nxera Pharma

Market Cap: JP¥74.8b

Develops and sells pharmaceutical products in Japan, the United States, Germany, Switzerland, Bermuda, and the United Kingdom.

Shin Nippon Biomedical Laboratories

Market Cap: JP¥69.6b

A contract research organization, engages in the pharmaceutical development, transactional research, and medipolis businesses in Japan and internationally.

ASKA Pharmaceutical HoldingsLtd

Market Cap: JP¥57.9b

Through its subsidiaries, engages in the pharmaceutical, animal health, and other businesses in Japan.

Cuorips

Market Cap: JP¥49.7b

Engages in the research, development, manufacture, commercialization, and sale of human iPS cell-derived cardiomyocyte sheets.

Fuji Pharma

Market Cap: JP¥46.2b

Engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally.

3-D Matrix

Market Cap: JP¥43.2b

3-D Matrix, Ltd. developing, manufacturing, and selling self-assembling peptide technology in Japan and internationally.

Heartseed

Market Cap: JP¥41.2b

Develops and commercializes iPS cell-derived cardiomyocyte replacement therapy for heart failure.

Daito PharmaceuticalLtd

Market Cap: JP¥40.0b

Engages in the manufacture and sale of pharmaceutical products in Japan and internationally.

Oncolys BioPharma

Market Cap: JP¥39.6b

Engages in the research, development, manufacturing, and sale of viral infectious disease treatment drugs in Japan, the United States, and Asia.

Seikagaku

Market Cap: JP¥38.8b

Manufactures and sells pharmaceuticals and medical devices primarily related to glycoconjugates in Japan and internationally.